
Singapore · Research startup
Mojia Biotech, founded in 2018, is a biomanufacturing company based in Singapore.
Funding reportedLast round: Series B
Follow Mojia Biotech and see its new rounds in your feed.Start following
Mojia Biotech, founded in 2018, is a biomanufacturing company based in Singapore.
The company specializes in sustainable chemical manufacturing technologies that utilize renewable carbon sources and green processes. Mojia Biotech focuses on producing food ingredients, animal-feed additives, and bio-based materials, all while promoting sustainability and carbon neutrality. The company operates R&D activities in China, Singapore, and the US, with manufacturing facilities in China. Mojia Biotech has developed proprietary platforms for enzyme and metabolic engineering, integrating biology, chemistry, and engineering to enhance chemical and polymer production. Their product lineup includes ViridiminTM, an innovative animal-feed additive, and the AliphaneTM Series, which features bio-based materials for various applications. The company has secured $80 million in Series B funding to support product commercialization and expand its global R&D efforts.
Funding, as reported
What they build
Known for
biotechnology researchandb2b
Built with from their website
WOWViewport MetaMicrosoft ExchangeMicrosoft 365 Apps & ServicesMobile FriendlyjQuerySwiperAnimate.cssGoDaddy DomainsMicrosoft Exchange Online
HSTSNginxMicrosoft 365OutlookPHPMicrosoft Email ProvidersGoDaddy Hosting
Add your raise, your deck and your story, and put Mojia Biotech in front of investors. Or tell us what we have wrong.